{
    "_id": "20493400|None",
    "id": "20493400",
    "infons": {},
    "passages": [
        {
            "infons": {
                "journal": "Immunol Allergy Clin North Am. 2010 May;30(2):249-60. doi: ",
                "year": "2010",
                "type": "title",
                "authors": "Cappelli B, Aiuti A"
            },
            "offset": 0,
            "text": "Gene therapy for adenosine deaminase deficiency.",
            "sentences": [],
            "annotations": [
                {
                    "id": "1",
                    "infons": {
                        "identifier": "MESH:C531816",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "C531816"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C531816",
                        "biotype": "disease",
                        "name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
                        "accession": "@DISEASE_Severe_combined_immunodeficiency_due_to_adenosine_deaminase_deficiency"
                    },
                    "text": "adenosine deaminase deficiency",
                    "locations": [
                        {
                            "offset": 17,
                            "length": 30
                        }
                    ]
                }
            ],
            "relations": []
        },
        {
            "infons": {
                "type": "abstract"
            },
            "offset": 49,
            "text": "In the last decade, gene therapy for adenosine deaminase deficiency has been developed as a successful alternative strategy to allogeneic bone marrow transplant and enzyme replacement therapy. Infusion of autologous hematopoietic stem cells, corrected ex vivo by retroviral vectors and combined to low-intensity conditioning regimen, has resulted in immunologic improvement, metabolic correction, and long-term clinical benefits. These findings have opened the way to applications of gene therapy in other primary immune deficiencies using novel vector technology.",
            "sentences": [],
            "annotations": [
                {
                    "id": "4",
                    "infons": {
                        "identifier": "MESH:C531816",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "C531816"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C531816",
                        "biotype": "disease",
                        "name": "Severe combined immunodeficiency due to adenosine deaminase deficiency",
                        "accession": "@DISEASE_Severe_combined_immunodeficiency_due_to_adenosine_deaminase_deficiency"
                    },
                    "text": "adenosine deaminase deficiency",
                    "locations": [
                        {
                            "offset": 86,
                            "length": 30
                        }
                    ]
                },
                {
                    "id": "5",
                    "infons": {
                        "identifier": "MESH:D007154",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "D007154"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D007154",
                        "biotype": "disease",
                        "name": "Immune System Diseases",
                        "accession": "@DISEASE_Immune_System_Diseases"
                    },
                    "text": "immune deficiencies",
                    "locations": [
                        {
                            "offset": 563,
                            "length": 19
                        }
                    ]
                }
            ],
            "relations": []
        }
    ],
    "relations": [],
    "pmid": 20493400,
    "pmcid": null,
    "meta": {},
    "date": "2010-05-01T00:00:00Z",
    "journal": "Immunol Allergy Clin North Am",
    "authors": [
        "Cappelli B",
        "Aiuti A"
    ],
    "relations_display": []
}